Showing 3 articles by David Ladenheim

Filters Content type: News, About HIV Author: David Ladenheim
Resistance

Further development of resistance infrequent in patients taking tenofovir despite low-level viremia and K65R mutation

News
11 April 2007
Starting treatment

Once-daily nevirapine has more side-effects than twice-daily dose, needs more study

News
14 February 2007
Resistance

Key resistance mutation fades in the long-term in most women who receive single-dose nevirapine

News
6 February 2007